AMY TAYLOR: Open Payments
NPI 1114397957 · FLAGSTAFF, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$228 in 13 payments from 8 companies in 2025. Trend: 2023 $663 · 2024 $848 · 2025 $228
Food & beverage: $228
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $64 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $42 |
| CARDIVA MEDICAL, INC. | 2 | $33 |
| Amgen Inc. | 2 | $29 |
| Novo Nordisk Inc | 1 | $21 |
| Edwards Lifesciences Corporation | 1 | $16 |
| PFIZER INC. | 1 | $14 |
| VivaQuant Inc, dba Rhythm Express | 1 | $9 |
Products named: LEQVIO, LifeVest, OPTOWIRE, REPATHA, Wegovy, SAPIEN 3 Ultra RESILIA, ELIQUIS, RHYTHM EXPRESS.
Industry payments across AZ — which companies pay providers there.
